Renal Cancer - Results from #2380

Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study. November 13, 2020

Extracorporeal Partial Nephrectomy with Orthotopic Autotransplantation under Pharmaco-Cold Ischaemia for Cancer of a Single Kidney: A Case Report. November 13, 2020

Prognostic factors in patients with small renal masses: a comparison between <2 vs. 2.1-4 cm renal cell carcinomas. November 12, 2020

Predicting the risk of pT3a stage in cT1 clear cell renal cell carcinoma. November 12, 2020

Combination therapy in metastatic renal cell carcinoma: Back to the future? November 12, 2020

Pathological complete response after nivolumab therapy following angiogenesis inhibitors in a patient with metastatic renal cell carcinoma. November 11, 2020

[Renal cell carcinoma in the department of Hérault: Results over a 30 year period]. November 11, 2020

Utilization of renal mass biopsy in patients with localized renal cell carcinoma: A population-based study utilizing the National Cancer Database. November 11, 2020

Pembrolizumab Plus Lenvatinib Demonstrated Statistically Significant Improvement in Progression-Free Survival, Overall Survival and Objective Response Rate Versus Sunitinib as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma November 10, 2020

Development and validation of a nomogram to predict overall survival for patients with metastatic renal cell carcinoma. November 10, 2020

[Expression of Hemeoxygenase-1 and clear cell renal cell carcinoma aggressiveness.] November 10, 2020

Systematic Review and STARD Scoring of Renal Cell Carcinoma Circulating Diagnostic Biomarker Manuscripts. November 10, 2020

Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells. November 9, 2020

MiR-483-5p downregulation contributed to cell proliferation, metastasis, and inflammation of clear cell renal cell carcinoma. November 9, 2020

Kidney cancer PDOXs reveal patient-specific pro-malignant effects of antiangiogenics and its molecular traits. November 9, 2020

Identified a Biomarker That Predicts the Increase in Malignancy That Antiangiogenic Therapy Can Cause in Kidney Cancers November 6, 2020

Kidney Cancer PDOXs Reveal Patient‐specific Pro‐malignant Effects of Antiangiogenics and Its Molecular Traits November 6, 2020

Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. November 6, 2020

Acute interstitial nephritis, a potential predictor of response to immune checkpoint inhibitors in renal cell carcinoma. November 6, 2020

Predictive role of γ-glutamyltransferase in patients receiving nivolumab therapy for metastatic renal cell carcinoma. November 6, 2020

Page 120 of 456